Getting a new product from the bench into the clinic is a complex endeavor. This webinar will provide an overview of the clinical, nonclinical, CMC, and regulatory activities necessary for a successful IND submission. Register Now.
Join us for The Three Keys to Winning in Life Sciences: Regulation, Technology, and Expectations Webinar with three Life Sciences experts as they discuss what device companies must do to get ahead of these pressures and others that face the industry if they want to stay competitive. Register Now
Companies rely on data about healthcare professionals (HCPs), healthcare organizations (HCOs), and their affiliations to manage customer engagement and ensure compliance.
The 2018 US Customer Reference Data Survey examines the current state of customer reference data in life sciences through the opinions and experiences of industry executives across the United States. Take the survey now!
In 2018 healthcare leaders will be adjusting their strategies to focus on investments, collaborations and efficiencies that build enterprise resilience on a baseline of continued uncertainty. Discover the risks and uncertainties are moving to center stage next year. Register now!
Join Cardinal Health Specialty Solutions as we review the biosimilar landscape and identify key strategies for overcoming regulatory barriers and getting your biosimilar to market quickly.
Atrium Innovations, an innovative leader in the development, manufacturing, and commercialization of science-based nutritional health products, is leveraging cloud technology to bring together 13 sites around the world and multiple functional groups. Register Now to learn more about cloud technology.
Join C3i Solutions’ thought leaders for an interactive webinar to discuss the importance of patient engagement in your organization, including striking the right balance between technology and that all- important human touch. Register now!
This webinar will give an overview of specific pediatric population challenges and focus on several key considerations for developing a new drug for pediatric patients. Register Now!
| Seton Hall
Don’t miss this educational program trusted by multi-national companies as part of their employee’s compliance training. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating in the Asia-Pacific region. Visit event page for session topics.
Download the Innovation Report today featuring category and best in show winners and interviews.
In this webinar, we’ll examine why regular risk analysis is so important, the data sources available, what the data can tell us, and how to leverage big data to deliver actionable insights. Register Now
When a biologics company prepares to launch a new product, it must forecast the capacity it will need. Download Patheon's whitepaper to learn how to mitigate risks by developing a manufacturing strategy that will accommodate a forecast range and allow you to adapt as better data becomes available.
Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives.
Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Download this white paper to see how you can manage the site feasibility process for predictable study enrollment – on time and on budget.
Enterprise resource planning (ERP) software has a proven track record in life sciences, particularly in the pharmaceutical arena.
Download this Whitepaper to gain insights on how quality ERP software can help you. Learn more.
Sourcing research externally seems to be the preferred path for biopharma companies to strengthen their R&D pipeline. But when choosing from the three main options open to them—licensing, mergers and acquisitions, and joint ventures—what factors should they examine, and do deal types differ in the ways they accelerate development and deliver long-term value?
In this article, based on an analysis of almost 3,000 biopharma deals over the past decade, Deloitte evaluates the pros and cons of each deal type, presents research on their relative success rates, and offers some reasons for success or failure. Learn more.